Pharmaceutical companies Moderna and Pfizer have announced price increases for their coronavirus vaccines. About it reported publication of the Financial Times with reference to supply contracts. The publication says that vaccines from both companies have been shown to be effective.
Pfizer has raised the price by more than 25% – from 15.5 to 19.5 euros per dose. Moderna has increased the cost by more than 12%, from $ 22.6 to $ 25.5 per dose (€ 21.5).
The European Commission and EU governments have agreed to pay a higher price to secure confirmed shipments from European manufacturing plants.
Pfizer previously raised its forecast for sales of the COVID-19 vaccine it produces with BioNTech by 29% – now the company expects its sales in 2021 to reach $ 33.5 billion. conveyed Kommersant. COVID-19 vaccine sales accounted for about 40% of all Pfizer sales in the second quarter. The company’s total revenue during this period increased by 92%, to $ 19 billion, and net profit – by 59%, to $ 5.6 billion.
Unlike other pharmaceutical companies, AstraZeneca and Johnson & Johnson, which promised not to make money on the vaccine until the end of the pandemic and sell it at cost, Pfizer did not make such a promise, although it was repeatedly criticized.